NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Renaissance BioScience Corp.

Renaissance BioScience Corp.

Private
Vancouver, British ColumbiaFrontier & Industrial Techhttps://renaissancebioscience.com/

Last Round

Grant

Feb 19, 2026

Total Funding Raised

$10.1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Renaissance BioScience Corp. is a bioengineering company that develops a platform for creating sustainable products in the food, agriculture, and health sectors using yeast.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

yeast engineeringsynthetic biologyacrylamide-reducing yeastRNAi delivery platformbiopesticidessynbiofood ingredientscrop protectioncustom strain developmentcell factoryfunctional microorganismsnon-GMO yeastVLP RNA deliveryfermentation yeast

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Renaissance BioScience Corp. Comparables

Compare Renaissance BioScience Corp. with similar companies based on industry and business-model similarity.

Renaissance BioScience Corp. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Conagen
78%
SenseUP
72%
Apolo Biotech
69%

Renaissance BioScience Corp. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 19, 2026
GrantSep 9, 2025
GrantFeb 8, 2024
Convertible DebtJun 30, 2023
GrantDec 3, 2021
Convertible Debt
Nov 4, 2021

Key People

Founding team and executive leadership

John Husnik

CSO And Office Of The CEO

Executive Team

Renaissance BioScience Corp. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 19, 2026

    $402K grant round led by Genome British Columbia.

  • Jan 2, 2026

    Monthly visitors grew 134% MoM, reaching 1.8K.

Renaissance BioScience Corp. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Renaissance BioScience Corp. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Renaissance BioScience Corp.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersVancouver, British Columbia
Employee Range25
Year Founded2013
Last FundingFeb 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.